Association of definitive pelvic radiation therapy with survival among patients with newly diagnosed metastatic cervical cancer
Menée aux Etats-Unis à partir des données du registre national des cancers portant sur 3 169 patientes atteintes d'un cancer métastatique du col de l'utérus récemment diagnostiqué (âge moyen : 53,6 ans ; durée médiane de suivi : 13 mois), cette étude analyse l'intérêt d'ajouter une radiothérapie pelvienne à une chimiothérapie pour améliorer la survie globale des patientes
Definitive pelvic chemoradiation is the standard of care for locally advanced cervical cancer.1 However, the role of definitive local radiation therapy for metastatic cervical cancer has not been established. In addition, there is growing evidence that local therapies may be associated with an increase in survival among patients with some types of metastatic cancers.2-5 In this study, we evaluated overall survival among patients with metastatic cervical cancer treated with chemotherapy alone vs pelvic chemoradiation.